Mizuho reaffirmed their neutral rating on shares of Tenet Healthcare Corporation (NYSE:THC) in a report published on Sunday. The firm currently has a $14.00 price target on the stock.

Several other analysts have also commented on THC. Citigroup Inc. reissued a neutral rating and set a $16.00 target price (down from $20.00) on shares of Tenet Healthcare Corporation in a research note on Thursday, August 10th. Deutsche Bank AG reissued a buy rating and set a $24.00 target price (down from $28.00) on shares of Tenet Healthcare Corporation in a research note on Thursday, August 10th. Robert W. Baird reissued an outperform rating and set a $23.00 target price on shares of Tenet Healthcare Corporation in a research note on Thursday, August 10th. Jefferies Group LLC reissued a buy rating and set a $24.00 target price (down from $26.00) on shares of Tenet Healthcare Corporation in a research note on Tuesday, August 8th. Finally, BidaskClub lowered shares of Tenet Healthcare Corporation from a hold rating to a sell rating in a research note on Saturday, August 5th. Three research analysts have rated the stock with a sell rating, nine have given a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of Hold and an average target price of $20.93.

Tenet Healthcare Corporation (NYSE:THC) opened at 14.45 on Friday. Tenet Healthcare Corporation has a 1-year low of $12.54 and a 1-year high of $24.96. The firm’s market capitalization is $1.46 billion. The firm’s 50-day moving average price is $17.36 and its 200-day moving average price is $17.86. Tenet Healthcare Corporation also was the target of some unusual options trading activity on Friday. Traders purchased 11,165 call options on the stock. This represents an increase of 775% compared to the average daily volume of 1,276 call options.

Tenet Healthcare Corporation (NYSE:THC) last posted its quarterly earnings data on Monday, August 7th. The company reported ($0.17) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.17). Tenet Healthcare Corporation had a negative net margin of 0.97% and a negative return on equity of 2.00%. The business had revenue of $14.80 billion during the quarter, compared to analysts’ expectations of $4.90 billion. During the same period last year, the firm posted $0.38 earnings per share. The business’s revenue was up 204.1% on a year-over-year basis. On average, equities research analysts predict that Tenet Healthcare Corporation will post $0.82 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Tenet Healthcare Corporation (THC) Receives Neutral Rating from Mizuho” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/08/21/tenet-healthcare-corporation-thc-receives-neutral-rating-from-mizuho.html.

Several hedge funds and other institutional investors have recently made changes to their positions in THC. Harris Associates L P raised its position in shares of Tenet Healthcare Corporation by 1.4% in the second quarter. Harris Associates L P now owns 7,733,435 shares of the company’s stock valued at $149,565,000 after buying an additional 108,070 shares during the period. Vanguard Group Inc. raised its position in shares of Tenet Healthcare Corporation by 6.2% in the second quarter. Vanguard Group Inc. now owns 6,995,269 shares of the company’s stock valued at $135,289,000 after buying an additional 407,910 shares during the period. Franklin Resources Inc. raised its position in shares of Tenet Healthcare Corporation by 25.0% in the second quarter. Franklin Resources Inc. now owns 5,000,000 shares of the company’s stock valued at $96,700,000 after buying an additional 1,000,000 shares during the period. FMR LLC raised its position in shares of Tenet Healthcare Corporation by 36.9% in the second quarter. FMR LLC now owns 3,724,713 shares of the company’s stock valued at $72,036,000 after buying an additional 1,004,700 shares during the period. Finally, State Street Corp raised its position in shares of Tenet Healthcare Corporation by 25.4% in the second quarter. State Street Corp now owns 2,926,533 shares of the company’s stock valued at $56,603,000 after buying an additional 593,520 shares during the period.

About Tenet Healthcare Corporation

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.

Analyst Recommendations for Tenet Healthcare Corporation (NYSE:THC)

Receive News & Stock Ratings for Tenet Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare Corporation and related stocks with our FREE daily email newsletter.